Prenetics Global (PRE) Net Income towards Common Stockholders (2021 - 2026)
Prenetics Global (PRE) posted quarterly Net Income towards Common Stockholders of -$23.1 million for Q1 2026, down 109.74% year-over-year from $237.2 million in Q1 2025, and down 206.35% quarter-over-quarter from -$7.5 million in Q4 2025.
Prenetics Global (PRE) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends
Prenetics Global (PRE) has reported Net Income towards Common Stockholders for 6 consecutive years, with -$23.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders fell 109.74% year-over-year to -$23.1 million; the TTM figure through Mar 2026 stood at -$52.1 million (down 0.57% YoY), while the FY2025 annual figure was -$37.7 million, up 18.56% from the prior year.
- Net Income towards Common Stockholders eased to -$23.1 million in Q1 2026 per PRE's latest filing, from -$7.5 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $4.4 million in Q4 2022 and bottomed at -$144.2 million in Q2 2022.
- Historically, Net Income towards Common Stockholders has averaged -$21.6 million across 5 years, with a median of -$12.7 million in 2025.
- On a YoY basis, Net Income towards Common Stockholders climbed as much as 105.09% in 2022 and fell as far as 1848.37% in 2022.
- Prenetics Global's Net Income towards Common Stockholders stood at $4.4 million in 2022, then sank by 549.11% to -$19.6 million in 2023, then increased by 10.57% to -$17.5 million in 2024, then surged by 57.01% to -$7.5 million in 2025, then slumped by 206.35% to -$23.1 million in 2026.
- Business Quant data shows PRE's Net Income towards Common Stockholders at -$23.1 million in Q1 2026, -$7.5 million in Q4 2025, and -$8.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Prenetics Global | 368.73 Mn | 309.68 Mn | 30.20 Mn | -8.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.98 Mn |
| Mar 31, 2026 | -23.47 Mn |
| Sep 30, 2025 | -7.41 Mn |
| Jun 30, 2025 | -12.41 Mn |
| Mar 31, 2025 | -10.39 Mn |
| Dec 31, 2024 | -46.79 Mn |
| Sep 30, 2024 | -10.67 Mn |
| Jun 30, 2024 | -10.93 Mn |
| Mar 31, 2024 | -9.00 Mn |
| Dec 31, 2023 | -62.72 Mn |
| Sep 30, 2023 | -14.00 Bn |
| Jun 30, 2023 | -22.21 Mn |
| Mar 31, 2023 | -10.97 Mn |
| Dec 31, 2022 | -195.30 Mn |
| Sep 30, 2022 | -14.90 Mn |
| Jun 30, 2022 | -144.18 Mn |
| Mar 31, 2022 | -424.95 Mn |
| Dec 31, 2021 | -174.01 Bn |
| Sep 30, 2021 | -80.41 Mn |
| Jun 30, 2021 | -9.78 Bn |